Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|
November 6, 2001
Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity
S Chodosh, J S Flanders, S Kesten, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer
D F Penson, M S Litwin, D P Lubeck, et al.
Prostate Cancer and Prostatic Diseases
|
February 3, 2016
Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science
N Nussbaum, D J George, A P Abernethy, et al.
Current Medical Research and Opinion
|
March 21, 2017
Docetaxel chemotherapy in metastatic castration-resistant prostate cancer: cost of care in Medicare and commercial populations
A Armstrong, C Bui, K Fitch, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|
November 6, 2001
Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity
S Chodosh, J S Flanders, S Kesten, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer
D F Penson, M S Litwin, D P Lubeck, et al.
Prostate Cancer and Prostatic Diseases
|
February 3, 2016
Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science
N Nussbaum, D J George, A P Abernethy, et al.
Current Medical Research and Opinion
|
March 21, 2017
Docetaxel chemotherapy in metastatic castration-resistant prostate cancer: cost of care in Medicare and commercial populations
A Armstrong, C Bui, K Fitch, et al.
Page
of 2